GlycoMimetics Inc (GLYC)
1.80
-0.12
(-6.49%)
USD |
NASDAQ |
Apr 22, 16:00
1.80
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Market Cap: 116.01M for April 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 116.01M |
| April 19, 2024 | 124.07M |
| April 18, 2024 | 139.21M |
| April 17, 2024 | 146.95M |
| April 16, 2024 | 138.57M |
| April 15, 2024 | 145.34M |
| April 12, 2024 | 154.68M |
| April 11, 2024 | 161.45M |
| April 10, 2024 | 157.90M |
| April 09, 2024 | 172.73M |
| April 08, 2024 | 166.93M |
| April 05, 2024 | 177.24M |
| April 04, 2024 | 174.66M |
| April 03, 2024 | 178.21M |
| April 02, 2024 | 190.77M |
| April 01, 2024 | 195.93M |
| March 28, 2024 | 193.35M |
| March 27, 2024 | 204.95M |
| March 26, 2024 | 183.68M |
| March 25, 2024 | 181.75M |
| March 22, 2024 | 188.84M |
| March 21, 2024 | 185.62M |
| March 20, 2024 | 196.57M |
| March 19, 2024 | 188.84M |
| March 18, 2024 | 180.46M |
| Date | Value |
|---|---|
| March 15, 2024 | 164.99M |
| March 14, 2024 | 168.07M |
| March 13, 2024 | 164.20M |
| March 12, 2024 | 168.71M |
| March 11, 2024 | 164.85M |
| March 08, 2024 | 175.79M |
| March 07, 2024 | 180.30M |
| March 06, 2024 | 186.74M |
| March 05, 2024 | 186.74M |
| March 04, 2024 | 195.76M |
| March 01, 2024 | 193.82M |
| February 29, 2024 | 186.10M |
| February 28, 2024 | 184.81M |
| February 27, 2024 | 194.47M |
| February 26, 2024 | 197.04M |
| February 23, 2024 | 186.74M |
| February 22, 2024 | 188.67M |
| February 21, 2024 | 192.54M |
| February 20, 2024 | 214.43M |
| February 16, 2024 | 207.35M |
| February 15, 2024 | 198.98M |
| February 14, 2024 | 198.33M |
| February 13, 2024 | 198.98M |
| February 12, 2024 | 200.26M |
| February 09, 2024 | 211.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.29M
Minimum
Jun 16 2022
566.54M
Maximum
May 06 2019
146.81M
Average
123.18M
Median
Jun 28 2021
Market Cap Benchmarks
| Altimmune Inc | 529.94M |
| Cellectar Biosciences Inc | 102.91M |
| PDS Biotechnology Corp | 109.67M |
| Syros Pharmaceuticals Inc | 132.00M |
| Precision BioSciences Inc | 66.95M |
Market Cap Related Metrics
| Price to Book Value | 3.02 |
| Price | 1.80 |
| Earnings Yield | -32.22% |